Treatment

This section provides basic information about treatment for hepatitis C. It is not meant to replace information from your medical specialist. Currently less than two per cent of people with hepatitis C are receiving treatment.

Telaprevir is a new drug recently introduced. It is used in combination with Peg-interferon and Ribavirin for people with Genotype 1. Links to information about Telaprevir on other websites.

Note: Links will open new windows.

HCV Advocate factsheet

- Basic information on Wikipedia

- Medscape article

- New England Medical Journal article

- ABC Science article

- Official Incivek website

 

 

Yes, with 50 to 80 per cent success rates.